[{"id":"95ff12bc-e7be-49e9-8642-0f09820d5e2a","acronym":"BK2016.01","url":"https://clinicaltrials.gov/study/NCT03146637","created_at":"2021-01-19T14:08:20.070Z","updated_at":"2024-07-02T16:36:35.301Z","phase":"Phase 2","brief_title":"Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer","source_id_and_acronym":"NCT03146637 - BK2016.01","lead_sponsor":"Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.","biomarkers":" GPC3","pipe":"","alterations":" ","tags":["GPC3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e activated CIK and bispecific antibody • activated CIK-anti-CD3/MUC1/CEA/EpCAM/GPC3 antibody"],"overall_status":"Recruiting","enrollment":" Enrollment 80","initiation":"Initiation: 05/01/2017","start_date":" 05/01/2017","primary_txt":" Primary completion: 01/27/2021","primary_completion_date":" 01/27/2021","study_txt":" Completion: 01/28/2021","study_completion_date":" 01/28/2021","last_update_posted":"2021-02-01"}]